Dermatological Autoimmune Considerations of Immune Checkpoint Therapy

The most common immune-related adverse events (irAEs) involve the skin, and several serve as predictors of response to immune checkpoint inhibitor (ICI) therapy, especially in melanoma. Patients with pre-existing skin autoimmune diseases (ADs) have been excluded from ICI studies for safety concerns,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fane, Lauren S., Efird, Jimmy T., Jindal, Charulata, Biswas, Tithi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598603/
https://www.ncbi.nlm.nih.gov/pubmed/36289601
http://dx.doi.org/10.3390/biomedicines10102339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598603/
https://www.ncbi.nlm.nih.gov/pubmed/36289601
http://dx.doi.org/10.3390/biomedicines10102339

Ejemplares similares